{"organizations": [], "uuid": "e5d6fe6cb8912a15437bee45ee25e1db4f91bfec", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/us-nestle-m-a-merck/nestle-frontrunner-for-merck-kgaas-consumer-health-business-bloomberg-idUSKBN1EZ1QS", "country": "US", "domain_rank": 408, "title": "Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-10T16:11:00.000+02:00", "replies_count": 0, "uuid": "e5d6fe6cb8912a15437bee45ee25e1db4f91bfec"}, "author": "", "url": "https://www.reuters.com/article/us-nestle-m-a-merck/nestle-frontrunner-for-merck-kgaas-consumer-health-business-bloomberg-idUSKBN1EZ1QS", "ord_in_thread": 0, "title": "Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg", "locations": [], "entities": {"persons": [{"name": "bloombe", "sentiment": "negative"}, {"name": "silke koltrowitz", "sentiment": "none"}, {"name": "mark potter", "sentiment": "none"}, {"name": "merck", "sentiment": "none"}], "locations": [{"name": "zurich", "sentiment": "none"}], "organizations": [{"name": "merck kgaa", "sentiment": "negative"}, {"name": "bloomberg", "sentiment": "negative"}, {"name": "nestle", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "stada", "sentiment": "none"}, {"name": "mylan nv", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "perrigo", "sentiment": "none"}, {"name": "reckitt benckiser group plc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 10, 2018 / 2:13 PM / in an hour Nestle frontrunner for Merck KGaA's consumer health business: Bloomberg Reuters Staff 1 Min Read \nZURICH (Reuters) - Nestle ( NESN.S ) is the frontrunner to buy Merck KGaAâ€™s ( MRCG.DE ) consumer health unit that could fetch as much as $5 billion, financial news service Bloomberg said on Wednesday, quoting unidentified sources familiar with the matter. \nBloomberg said Nestle had submitted the highest offer and Merck was likely to select a winner during the first quarter, but might also choose not to sell the assets after all. \nIt quoted sources saying that generic drugmaker Perrigo ( PRGO.N ) and the private equity owners of German drug firm Stada ( STAGn.DE ) had dropped out of the process, while Reckitt Benckiser Group Plc ( RB.L ) and Mylan NV ( MYL.O ) were still suitors for the business. \nA spokeswoman for Nestle said the company was not commenting on rumors. Reporting by Silke Koltrowitz; Editing by Mark Potter", "external_links": [], "published": "2018-01-10T16:11:00.000+02:00", "crawled": "2018-01-10T16:22:28.016+02:00", "highlightTitle": ""}